IG Review of FISA Compliance Completed But Not Released
The Office of the Inspector General (OIG) of the Department of Justice said it had recently completed a review of the Department’s use of Section 702 of the Foreign Intelligence Surveillance Act (FISA) Amendments Act (FAA), but the report is classified and its findings have not been released.
“The OIG examined the number of disseminated FBI intelligence reports containing a reference to a U.S. person identity, the number of U.S. person identities subsequently disseminated in response to requests for identities not referred to by name or title in the original reporting, the number of targets later determined to be located in the United States, and whether communications of such targets were reviewed. The OIG also reviewed the FBI’s compliance with the required targeting and minimization procedures,” according to a November 7 OIG memorandum on Top Management and Performance Challenges in the Department of Justice.
A copy of the classified report has been requested under the Freedom of Information Act.
Earlier this year, Sen. Ron Wyden placed a hold on reauthorization of the FISA Amendments Act “because I believe that Congress does not have enough information about this law’s impact on the privacy of law-abiding American citizens, and because I am concerned about a loophole in the law that could allow the government to effectively conduct warrantless searches for Americans’ communications.”
With wildfire risk increasing and the potential for destruction along with it continues to grow nationwide, the Federation of American Scientists (FAS) today joins with other organizations to launch a new coalition, Partners in Wildfire Prevention.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.